At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
New Prostate Cancer Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new medication to treat prostate cancer.
Is Prostate Cancer Surgery Recommended For Everyone?
For some men with prostate cancer, surgery may not be more beneficial than observation, according to a new study.
A Possible Risk of Androgen Deprivation Therapy
Men with prostate cancer who take androgen-lowering medication may have a raised risk of dementia, a new study found.
Prostate Cancer Imaging Just Got a Boost
The US Food and Drug Administration (FDA) recently approved a new diagnostic imaging tool to detect prostate cancer that has come back after treatment.
Cancer Screening: It Could Be Hard to Get the Facts
Most people would agree that cancer screening is a good thing. After all, you're either preventing cancer or catching it early. Unfortunately, the majority of cancer screening guidelines may be lacking in important patient information.
Cancer Screening: The Downside of Vigilance
There's no doubt about it: preventative cancer screening can save lives. But new evidence suggests that some screenings may be inappropriate and even risky.
Gene-Targeted Rx Offers Hope for Prostate Cancer
Prostate cancer can be tough to treat once it has spread throughout the body. But a new, gene-targeting pill may soon be here to help.
How Ethnicity Affects Cancer Risk
Your ethnicity may be a factor in your cancer risk.
This Common Diabetes Rx May Be Safer Than Previously Thought
Weighing the benefits of medications against their potential risks is a common conundrum for many doctors. But, for one common diabetes medication, that decision may have gotten a little easier.
The Changing Course of Prostate Cancer Treatment
Treating prostate cancer is a balancing act — not too much treatment, but not too little. And it looks as though doctors may be getting better at balancing.